RecruitingNCT05566392

Longterm Influence of Pediatric Long COVID Syndrome

Longterm Influence of Pediatric Long COVID Syndrome on the Neuropsychiatric Function, Social Function, Neuroimage, and Gut Microbiota


Sponsor

National Taiwan University Hospital

Enrollment

500 participants

Start Date

Oct 20, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation


Eligibility

Min Age: 6 YearsMax Age: 18 Years

Inclusion Criteria2

  • Age 6-18 years old
  • Has been diagnosed COVID-19 before

Exclusion Criteria2

  • History of neuropsychiatric disorders
  • Have some device not allowed for MRI

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBrain MRI

Brain MRI including diffusion spectrum image, and functional MRI Interview with questionnaires for neuropsychiatric evaluation Near infrared spectroscopy and resting-state connectivity evaluation


Locations(1)

National Taiwan University Children Hospital Pediatric Neurology Department

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05566392


Related Trials